DexCom DXCM Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by DexCom in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about DexCom's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is DexCom's financing cash flow?
- DexCom (DXCM) reported financing cash flow of -$25M in Q1 2026.
- How has DexCom's financing cash flow changed year-over-year?
- DexCom's financing cash flow decreased by 300.0% year-over-year, from $12.5M to -$25M.
- What is the long-term trend for DexCom's financing cash flow?
- Over 3 years (2022 to 2025), DexCom's financing cash flow has grown at a 45.1% compound annual growth rate (CAGR), from -$552.5M to -$1.69B.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.